1988
DOI: 10.1111/j.1749-6632.1988.tb27060.x
|View full text |Cite
|
Sign up to set email alerts
|

Strategies for the Treatment of Myasthenia Gravis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1991
1991
2018
2018

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 21 publications
(2 citation statements)
references
References 50 publications
0
2
0
Order By: Relevance
“…Immunoglobulins to postsynaptic receptors have not yet been identified following neurotoxic exposures but are likely to play a role in neuropathy. This is recognized in myasthenia gravis with autoantibodies to the nicotinic acetylcholine (ACh) receptor (49), antimuscarinic (m)AChR in Chagas disease (162), and anti-P-adrenoceptors in dilated cardiomyopathy (163,164).…”
Section: Anti-nf-68mentioning
confidence: 99%
“…Immunoglobulins to postsynaptic receptors have not yet been identified following neurotoxic exposures but are likely to play a role in neuropathy. This is recognized in myasthenia gravis with autoantibodies to the nicotinic acetylcholine (ACh) receptor (49), antimuscarinic (m)AChR in Chagas disease (162), and anti-P-adrenoceptors in dilated cardiomyopathy (163,164).…”
Section: Anti-nf-68mentioning
confidence: 99%
“…This disease also presented in both Vietnamese men and women, with a female/ male ratio of 1.2:1 which is lower than the previously reported ratio of 1.5:1 in a Western population. 4 MG was common in this cohort of thymoma patients (84.9%); most were class I and IIA (37.8% and 62.2%, respectively). In a Western population, Strollo and colleagues 5 reported a lower rate of MG of 30%-50% in thymoma patients.…”
Section: Discussionmentioning
confidence: 73%